Peer video coaching shows promise for HIV medication adherence in young adults
NCT ID NCT04499781
First seen Nov 01, 2025 · Last updated Jun 20, 2026 · Updated 25 times
Summary
This study tested whether weekly video chats with trained HIV+ peer coaches could help Black and Hispanic young adults (ages 18-29) take their HIV medication more consistently. Sixty participants either received eight video coaching sessions or accessed web-based HIV education. The goal was to improve medication adherence and lower viral load. The trial is now complete, and results will show if this supportive approach makes a real difference.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Jacobi Medical Center
The Bronx, New York, 10461, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
peer health coaching via videoconferencing
What this could lead to
If it works, this approach could offer a practical, supportive way to help young people with HIV stay on their medication and keep the virus under control.
What could go wrong
This is a small, completed trial (60 participants) testing a behavioral intervention, not a new drug or cure. Results may not apply to all groups, and adherence improvements may not last long-term.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.